You are here

  • Home
  • Archive
  • Volume 79, Issue 10
  • Response to: ‘On using machine learning algorithms to define clinically meaningful patient subgroups’ by Pinal-Fernandez and Mammen

Article info

Article menu

Download PDFPDF

Correspondence response
Response to: ‘On using machine learning algorithms to define clinically meaningful patient subgroups’ by Pinal-Fernandez and Mammen
Free

Authors

  • Olivier Benveniste Department of Internal Medicine and Clinical Immunology and Paris Neuromuscular Rare Diseases Reference Center, Sorbonne Université, INSERM U974, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Paris, France PubMed articlesGoogle scholar articles
  • Yves Allenbach Department of Internal Medicine and Clinical Immunology and Paris Neuromuscular Rare Diseases Reference Center, Sorbonne Université, INSERM U974, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Paris, France PubMed articlesGoogle scholar articles
  • Benjamin Granger Department of Biostatistics and Clinical Information, Sorbonne Université, INSERM UMR 1136, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Paris, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Olivier Benveniste, Department of Internal Medicine and Clinical Immunology, Hospital University Department: Inflammation, Immunopathology and Biotherapy (DHU i2B), Assistance Publique - Hôpitaux de Paris, Pitié-Salpêtrière University Hospital, Paris 75013, France; olivier.benveniste{at}aphp.fr
View Full Text

Citation

Benveniste O, Allenbach Y, Granger B
Response to: ‘On using machine learning algorithms to define clinically meaningful patient subgroups’ by Pinal-Fernandez and Mammen
Annals of the Rheumatic Diseases 2020;79:e130.

Publication history

  • Received July 10, 2019
  • Revised July 10, 2019
  • Accepted July 12, 2019
  • First published July 20, 2019.
Online issue publication 
April 07, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.